Clinical Trial Update: Effects of Terlipressin and Somatostatin on Portal Pressure in Patients Undergoing Living Donor Liver Transplantation [NA]

View source ↗

Summary

A clinical trial evaluating the effects of terlipressin and somatostatin on portal pressure in patients undergoing living donor liver transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Liver Disease
• Liver Cirrhosis
• Portal Hypertension

Drugs mentioned

• Somatostatin (somatostatin)
• Terlipressin (terlipressin)

Snippet

Sponsor: Istanbul Medipol University Hospital | Conditions: Liver Transplantation, Portal Hypertension | NA | Status: NOT_YET_RECRUITING